In Her2-high SKBR-3 and HCC1954 breast cancer cells, T-DM1 and Trastuzumab-SB-DM1 showed comparable reduction of cell viability, similar to DM1 alone, while the naked antibody showed no effect on cell viability (Fig. 2c). The gene discussed is ERBB2; the disease is breast carcinoma.